IM Cannabis reports sales in Germany are up 50% | How to buy Skittles Moonrock online

Learn where to order cannabis online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) announced that the Preliminary sales results You can also find out more about the following: Germany Adjupharm GmbH, IMC Germany’s German subsidiary, has significantly exceeded expectations for the third quarter 2024. The company reported a 50% increase in revenue from the second quarter when IMC Germany had sold about C$3.5 Million.

Adjupharm GmbH distributes medical cannabis to pharmacies.

The company stated that the company’s outstanding growth was a result of the successful execution and market demand for their products.

“Since April 1One of our key goals was to ensure that the supply chain was strong enough to meet demand growth. This preliminary 50% increase is testament to this objective, in part,” said Oren ShusterIMC’s CEO. “We are delighted with our Q3 results, which not only exceeded our own targets but also highlighted the dedication and hardwork of our entire staff.”

In August, IM Cannabis announced its sales figures. second-quarter Results, where revenue grew 12% over the past year to C$14.8 from C$13.2 millions. Germany sales were up 129%, to C$3.5million after the country Legalized Personal possession of marijuana and nonprofit marijuana clubs were legalized in April. Germany now accounts for 24% of company revenue.

IM Cannabis also noted the partial legalization cannabis in Germany In April, after the new law was passed, the demand for cannabis products in pharmacy increased dramatically, highlighting how important it is to have a reliable and robust supply chain.

CFO Uri Berenberg also stated in August that the price of cannabis flower had increased by 21% due to German legalization. The price was C$6.09 for a gram. IMC also reduced its operating costs by 29% during the second quarter to C$3.7million, as it sought to find the right balance for profitability.

In its August management analysis, the company stated that it plans to leverage the foundation created by Adjupharm and its EU-GMP certified production facilities in Germany, as well as its vast knowledge of cannabis markets and customer preferences, and its network distribution partners, to expand to other jurisdictions on the continent.